Methods for screening for antimicrobials utilizing AarC and compositions thereof
AssigneeCase Western Reserve University
InventorPhilip N. Rather
Life of this patent
Estimating the term…
Loading patent…
AssigneeCase Western Reserve University
InventorPhilip N. Rather
Estimating the term…
The present invention provides an oligonucleotide (aarC) which encodes a novel bacterial polypeptide (AarC) that is essential for the viability of bacteria. The invention provides recombinant expression vectors comprising the nucleotide sequence encoding AarC, as well as host cells containing these expression vectors. Further provided herein are methods for screening bacteria which contain aarC or variants or homologs thereof. Also provided are methods for using the aarC oligonucleotide sequence to screen antimicrobials which target AarC activity in gram negative and gram positive bacteria. Additionally, the invention provides for the use of aarC in diagnostic assays which utilize the aarC oligonucleotide to hybridize with nucleic acid sequences encoding AarC as well as with AarC mRNA. The invention further describes monoclonal and polyclonal AarC antibodies and their use in diagnostic assays for the detection of bacteria which express AarC.
A substantially purified polypeptide comprising a portion of the amino acid sequence of SEQ ID NO:5, said portion of SEQ ID NO:5 having a length greater than 65 amino acid residues.
A substantially purified polypeptide consisting of the amino acid sequence of SEQ ID NO:5.
A substantially purified polypeptide consisting of the amino acid sequence of SEQ ID NO:5 linked to a heterologous metal chelating peptide.
Dependencies are inferred from the claim text.